skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

99+ Total results for product and free and sample content found

HBW Insight : コンシューマーヘルスケア産業のニュース

Nestlé To Enter Europe's CBD Market With UK Launch

CBD Nestle Launch

Nestlé Health Science is expanding its CBD offering outside the US with the UK launch of a dietary supplement formulated by cannabis development firm Geocann.

Topic Consumer EU

Medtech Insight: 世界の医療機器・医療技術の最新情報

Lack Of Joined Up Data Must Be Addressed By Registries In New UK Device Legislation

The Cumberlege Review of patient safety delivered a damning verdict on the UK’s health system. Its recommendations must be acted on, says a consensus of stakeholders.

Topic policy-and-regulation medtech

Medtech Insight: 世界の医療機器・医療技術の最新情報

Cognoa Seeks De Novo Clearance For AI-Powered Diagnostic App For Autism After Successful Study

FDA clearance of the ASD Diagnostic app could lead to early diagnosis, improving quality of life of children with ASD and their caregivers.

Topic Diagnostics digital-health fda

Generics Bulletin: ジェネリック&バイオシミラーニュース

EMA Endorses Dexamethasone For COVID-19

Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.

Topic Coronavirus policy-and-regulation

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Coronavirus Update: Moderna And Pfizer Respond To Vaccine Trial Transparency Demands

Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for transparency.

Topic Coronavirus Manufacturing clinical-trials

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

First COVID-19 Trial Success For Roche's Actemra, But No Sign It Saves Lives

A composite endpoint conceals Actemra’s lack of mortality benefit – while life-saving dexamethasone gets EMA endorsement.

Topic Coronavirus

Generics Bulletin: ジェネリック&バイオシミラーニュース

AAM Ramps Up US Election Lobbying

The AAM has published a timely guide highlighting various voter issues of concern in the run-up to the US elections, including anti-competitive tactics building on monopoly pricing and weak patent laws. The AAM has also called for policies to encourage generic and biosimilar entry in the market while the guide also focuses on policies around the US supply chain.

Topic US Election 2020 Policy & Regulation

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Six Pharma CEOs To Testify In House as Democrats, Trump Compete For Attention On Drug Pricing

US Election Drug Pricing Debate

While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.

Topic us-election-2020 drug-pricing

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

'March In' Plan Unveiled By Democratic Think Tank: A Battle Biopharma Would Welcome?

In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.

Topic us-election-2020 drug-pricing

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。